The American Diabetes Association (ADA) and the Centers for Medicare and Medicaid Services (CMS) have announced a Part D Senior Savings Model, which will limit the cost of insulin for participating seniors to a maximum of $35 for a 30-day supply.
The ADA has been pressing federal and state policymakers for years to help lower the cost of insulin and other drugs for people living with diabetes – 7m of whom are insulin-dependent. The CMS savings program is the first federal measure to drive insulin costs down.
People with diabetes account for one of every three dollars spent on drugs in the United States, and they spend about 2.5 times more on healthcare expenses than other Americans.
“Together, we are helping 3.3m seniors access insulin more affordably,” said Tracey D. Brown, CEO of the American Diabetes Association.
“The American Diabetes Association is committed to continuing the fight to make insulin and other drugs more affordable so that people living with diabetes can thrive, particularly in these historically challenging times.”